Switch to:
More From Other Websites
PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events Jun 28 2016
Puma (PBYI) Submits Neratinib Marketing Application in EU Jun 28 2016
Puma Biotechnology Submits Marketing Authorization Application for PB272 (Neratinib) as Extended... Jun 27 2016
Puma Biotechnology Submits Marketing Authorization Application for PB272 (Neratinib) as Extended... Jun 27 2016
PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Jun 15 2016
PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events Jun 06 2016
Puma (PBYI) Presents Favorable Phase II Data on Neratinib Jun 06 2016
Puma Biotechnology Presents Positive Phase II Data at the 2016 ASCO Annual Meeting Jun 05 2016
Puma Biotechnology Presents Positive Phase II Data at the 2016 ASCO Annual Meeting Jun 05 2016
Puma Biotechnology, Inc. :PBYI-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 Jun 01 2016
Key Movers to Look for Ahead of ASCO May 29 2016
5 Major Clinical Trial Results Coming Up May 25 2016
PUMA BIOTECHNOLOGY, INC. Financials May 19 2016
Puma Biotechnology Announces Publication of Neratinib Abstract for the 2016 ASCO Annual Meeting May 18 2016
Puma Biotechnology Announces Publication of Neratinib Abstract for the 2016 ASCO Annual Meeting May 18 2016
Puma Biotechnology to Present at UBS Global Healthcare Conference May 17 2016
Puma Biotechnology to Present at UBS Global Healthcare Conference May 17 2016
XBI Dropped, Markets Fell Due to Retail Sector Concerns May 12 2016
Puma (PBYI) Reports Wider Loss in Q1, Neratinib in Focus May 11 2016
Puma Biotech reports 1Q loss May 10 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK